Disclosures for "The Exit Strategy: Clinical Outcomes and Safety of De-escalating High-efficacy Therapies in Multiple Sclerosis"
Dr. Osen has nothing to disclose.
Dr. Madineni has nothing to disclose.
Dr. Dew has nothing to disclose.